EXMceuticals (FRA:9OM1) Change In Receivables : €0.01 Mil (TTM As of Mar. 2021)

View and export this data going back to 2015. Start your Free Trial

What is EXMceuticals Change In Receivables?

EXMceuticals's change in receivables for the quarter that ended in Mar. 2021 was €-0.02 Mil. It means EXMceuticals's Accounts Receivable increased by €0.02 Mil from Dec. 2020 to Mar. 2021 .

EXMceuticals's change in receivables for the fiscal year that ended in Jun. 2020 was €0.03 Mil. It means EXMceuticals's Accounts Receivable declined by €0.03 Mil from Jun. 2019 to Jun. 2020 .

EXMceuticals's Accounts Receivable for the quarter that ended in Mar. 2021 was €0.18 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. EXMceuticals's liquidation value for the three months ended in Mar. 2021 was €-1.57 Mil.

EXMceuticals Change In Receivables Historical Data

The historical data trend for EXMceuticals's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EXMceuticals Change In Receivables Chart

EXMceuticals Annual Data

Trend

Jun11

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Change In Receivables

Get a 7-Day Free Trial

-0.08

-0.09

0.03

EXMceuticals Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Change In Receivables	Get a 7-Day Free Trial															-0.06	0.13	-0.01	-0.10	-0.02

EXMceuticals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.01 Mil.

EXMceuticals (FRA:9OM1) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

EXMceuticals's Days Sales Outstanding for the quarter that ended in Mar. 2021 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.175	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, EXMceuticals's accounts receivable are only considered to be worth 75% of book value:

EXMceuticals's liquidation value for the quarter that ended in Mar. 2021 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.229	-	1.932	+	0.75 * 0.175	+	0.5 * 0
=	-1.57

EXMceuticals Change In Receivables Related Terms

Thank you for viewing the detailed overview of EXMceuticals's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

EXMceuticals (FRA:9OM1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EXMceuticals Inc (FRA:9OM1) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

421 7th Avenue S.W., 30th Floor, Calgary, AB, CAN, T2P 4K9

Website

http://www.exmceuticals.com

EXMceuticals Inc is a bio-science company that believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with ambition and potential to become the suppliers of highest-grade cannabis ingredients. It is creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. It has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients and API's to the pharmaceutical, medicinal and wellness industry.

EXMceuticals (FRA:9OM1) Headlines

No Headlines